Literature DB >> 33290195

Impact of Guidelines on Hypertension Control in the Elderly.

Del Pinto Rita1, Mirela Dobre2, Silvia Pagliacci3, Claudio Ferri1.   

Abstract

BACKGROUND: Hypertension control is a crucial measure to reduce cardiovascular (CV) risk, and blood pressure (BP) treatment targets have been recently revised to address this issue. However, achieving the recommended goal may be challenging.
OBJECTIVE: We aimed to assess the prevalence of uncontrolled hypertension, according to the US hypertension guidelines, among elderly participants in an Italian nationwide epidemiological survey, the relevant clinical correlates, and the agreement with the application of the European guidelines.
METHODS: Elderly (≥65y) volunteers enrolled in an Italian nationwide survey underwent BP measurement using standard protocols. Uncontrolled hypertension was defined as BP≥130/80 mmHg. Agreement of this definition with those from European guidelines (≥140/90 mmHg; ≥140/80 mmHg) was tested using Cohen's kappa. Selfreported information on modifiable/non-modifiable CV risk factors was also collected.
RESULTS: Of the 13,162 treated hypertensive elderly, 69.8% had uncontrolled hypertension. They tended to be overweight/obese men with diabetes. Overall agreement between US and European guidelines was poor to good (κ = 0.289, p<0.001 and κ = 0.691, p<0.001 based on the 140/90 and 140/80 mmHg threshold, respectively). Elderly participants with controlled hypertension were more likely to report a history of CV or chronic kidney disease. No difference in lifestyle habits was observed by BP control status.
CONCLUSION: Real-world data identify limited concordance between guidelines in terms of BP target achievement among older hypertensive Italians and highlights the need to spread awareness of the CV risk, especially in the presence of diabetes and obesity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Hypertension; cardiovascular diseases; care planning; life style; patient; risk reduction behavior; surveys and questionnaires.

Mesh:

Substances:

Year:  2021        PMID: 33290195      PMCID: PMC9167062          DOI: 10.2174/1381612826666201207230956

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.310


  62 in total

1.  Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC).

Authors:  Mats Borjesson; Mikael Dellborg; Josef Niebauer; Andre LaGerche; Christian Schmied; Erik E Solberg; Martin Halle; Emilio Adami; Alessandro Biffi; Francois Carré; Stefano Caselli; Michael Papadakis; Axel Pressler; Hanne Rasmusen; Luis Serratosa; Sanjay Sharma; Frank van Buuren; Antonio Pelliccia
Journal:  Eur Heart J       Date:  2019-01-01       Impact factor: 29.983

Review 2.  When to use the Bonferroni correction.

Authors:  Richard A Armstrong
Journal:  Ophthalmic Physiol Opt       Date:  2014-04-02       Impact factor: 3.117

3.  Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.

Authors:  JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; Christine M Albert; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

Review 4.  Hypertension Management at Older Age: An Update.

Authors:  Rita Del Pinto; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-22

5.  Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study.

Authors:  Claudio Borghi; Florence Tubach; Guy De Backer; Jean Dallongeville; Eliseo Guallar; Jesús Medina; Joep Perk; Carine Roy; José R Banegas; Fernando Rodriguez-Artalejo; Julian P Halcox
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

Review 6.  More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.

Authors:  Paolo Verdecchia; Fabio Angeli; Giorgio Gentile; Gianpaolo Reboldi
Journal:  Hypertension       Date:  2016-07-25       Impact factor: 10.190

7.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

Authors:  Sharon H Saydah; Judith Fradkin; Catherine C Cowie
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

8.  Physical activity recommendations and decreased risk of mortality.

Authors:  Michael F Leitzmann; Yikyung Park; Aaron Blair; Rachel Ballard-Barbash; Traci Mouw; Albert R Hollenbeck; Arthur Schatzkin
Journal:  Arch Intern Med       Date:  2007-12-10

9.  Vitamin D deficiency and risk of cardiovascular disease.

Authors:  Thomas J Wang; Michael J Pencina; Sarah L Booth; Paul F Jacques; Erik Ingelsson; Katherine Lanier; Emelia J Benjamin; Ralph B D'Agostino; Myles Wolf; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-01-07       Impact factor: 29.690

10.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

View more
  1 in total

1.  TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice.

Authors:  Krzysztof J Filipiak; Miguel Camafort Babkowski; Matteo Cameli; Stefano Carugo; Claudio Ferri; Djamshid B Irisov; Krzysztof Narkiewicz; Ulugbek Nizamov; Leopoldo Pérez de Isla; Anna Tomaszuk-Kazberuk; Andrea Ungar; Aleksandra Gąsecka
Journal:  Cardiol J       Date:  2022-09-19       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.